Episode

Episode 55: Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®

Podcast: Few & Far Between: How Biotech Gets Built
Published: Jul 9, 2025
Duration seconds: 2326
Processing state: not_requested
Canonical source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-56-julio-g-martinez-clark-ceo-and-co-founxst
Audio: https://dts.podtrac.com/redirect.mp3/episodes.castos.com/6026d270a471b8-76273800/2083782/c1e-q414ghdd3wdhnr8pp-z3kzq6d4idk4-dchrde.mp3
JSON: /v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/episode-55-julio-g-martinez-clark-ceo-and-co-founder-at-bioaccess
Markdown: /podcast/few-far-between-how-biotech-gets-built-4067896/episode-55-julio-g-martinez-clark-ceo-and-co-founder-at-bioaccess.md

Actions

POST https://stenobird.com/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/episode-55-julio-g-martinez-clark-ceo-and-co-founder-at-bioaccess/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-55-julio-g-martinez-clark-ceo-and-co-founder-at-bioaccess.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

How much do you know about clinical trials in Latin America? Take a deep dive with us as we explore the benefits and risks of running studies in this region. In our latest episode of the Biorasi Few & Far Between podcast, host Chris O'Brien welcomes Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®. Tune in as we spotlight the advantages of running studies in #LATAM - from data quality to speed to approval.